logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11135156 B1

PDFFull Text
Date of Patent:
Oct. 05, 2021

Filed:

May. 23, 2017

Pharmaceutical tablet for use in administering one or more pharmaceutically active ingredients

Applicant:

Fertin Pharma A/s, Vejle, DK;

Inventors:

Martin Topsoe, Vejle, DK;

Kirsten Lund, Juelsminde, DK;

Assignee:

FERTIN PHARMA A/S, Vejle, DK;

Attorney:
Primary Examiner:

Michael G Hartley

Assistant Examiner:

Lance W Rider

Int. Cl.
CPC ...
A61K 9/00 (2006.01); A23G 3/36 (2006.01); A23G 4/20 (2006.01); A23G 4/08 (2006.01); A23G 4/18 (2006.01); A24B 13/00 (2006.01); A61K 9/68 (2006.01); A61K 9/20 (2006.01); A23L 33/10 (2016.01); A23G 3/42 (2006.01); A24B 15/10 (2006.01); A23G 4/10 (2006.01); A61K 31/465 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A23G 3/36 (2013.01); A23G 3/42 (2013.01); A23G 4/08 (2013.01); A23G 4/10 (2013.01); A23G 4/18 (2013.01); A23G 4/20 (2013.01); A23L 33/10 (2016.08); A24B 13/00 (2013.01); A24B 15/10 (2013.01); A61K 9/0058 (2013.01); A61K 9/2027 (2013.01); A61K 31/465 (2013.01); A23V 2002/00 (2013.01);
Abstract

A pharmaceutical tablet for use in administering one or more pharmaceutically active ingredients, comprising a polymer system, the one or more pharmaceutically active ingredients, a flavor, and a sweetener, wherein at least 20% by weight of the pharmaceutical tablet comprises substantially non-elastomeric polymer and less than 5% by weight of the pharmaceutical tablet comprises one or a combination of elastomeric polymers, and wherein the pharmaceutical tablet comprises at least 70% by weight of said polymer system comprising polyvinyl acetate (PVA) and less than 10% by weight of said polymer system comprising polymer having a molecular weight (Mw) greater than 50,000 g/mol.

Find Patent Forward Citations

Loading…